Precision Optics Corporation to Participate in Investor Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 18 2026
0mins
Source: Newsfilter
- Investor Conference Participation: Precision Optics Corporation will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026, featuring a webcast presentation and one-on-one meetings with investors to showcase its advanced optical instrument design and manufacturing capabilities in the medical and defense/aerospace sectors.
- Webcast Details: The webcast is scheduled to begin at 1:00 p.m. ET, and investors can access it via the conference homepage or directly through a provided link, with a replay available post-event to ensure information dissemination to those unable to attend live.
- One-on-One Meeting Arrangements: Management will engage in virtual one-on-one meetings throughout the event, allowing investors to arrange discussions through Lytham Partners, thereby enhancing understanding of the company's business and future developments.
- Company Background Overview: Founded in 1982, Precision Optics focuses on micro-optics, 3D imaging, and digital imaging technologies, providing comprehensive services from new product concepts to mass production, addressing the increasing demands of the healthcare and defense/aerospace markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy POCI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on POCI
About POCI
Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Precision Optics Corporation to Participate in Investor Conference
- Investor Conference Participation: Precision Optics Corporation will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026, featuring a webcast presentation and one-on-one meetings with investors to showcase its advanced optical instrument design and manufacturing capabilities in the medical and defense/aerospace sectors.
- Webcast Details: The webcast is scheduled to begin at 1:00 p.m. ET, and investors can access it via the conference homepage or directly through a provided link, with a replay available post-event to ensure information dissemination to those unable to attend live.
- One-on-One Meeting Arrangements: Management will engage in virtual one-on-one meetings throughout the event, allowing investors to arrange discussions through Lytham Partners, thereby enhancing understanding of the company's business and future developments.
- Company Background Overview: Founded in 1982, Precision Optics focuses on micro-optics, 3D imaging, and digital imaging technologies, providing comprehensive services from new product concepts to mass production, addressing the increasing demands of the healthcare and defense/aerospace markets.
See More
Precision Optics Reports Q3 Earnings with Strong Revenue Growth
- Significant Revenue Growth: Precision Optics reported Q3 revenue of $8.7 million, reflecting a 107.1% year-over-year increase, indicating strong performance amid market demand recovery, which is expected to further drive future financial results.
- Order Expansion: The company received a $3.5 million follow-on production order for its single-use ophthalmic program, with shipments expected to commence in the fourth fiscal quarter, enhancing the product line and boosting market competitiveness.
- Upward Financial Guidance: The company raised its fiscal year 2026 revenue guidance to a range of $29 to $31 million, up from the previous $26 to $28 million, reflecting confidence in future growth and projecting a 52% to 62% year-over-year increase.
- Improved EBITDA Expectations: The adjusted EBITDA guidance has also been revised upward to a range of $(2.5) to $(2.7) million, compared to the previous $(2.5) to $(3.0) million, demonstrating ongoing improvements in cost control and operational efficiency.
See More
Precision Optics Corporation Prices Public Offering
- Public Offering Pricing: Precision Optics Corporation has announced a public offering of 2.77 million shares at a price of $3.60 per share, which has led to a 2.72% decline in stock price to $4.12, indicating a negative market reaction to the offering.
- Underwriter Option: The company has granted the underwriter a 45-day option to purchase an additional 420,000 shares at the public offering price, which may provide the company with additional financial flexibility despite market volatility.
- Use of Proceeds: The net proceeds from this offering will be used for working capital and general corporate purposes, indicating the company's focus on enhancing financial stability while potentially facing challenges in capital efficiency.
- Market Performance: POCI shares have traded between $3.55 and $4.16 over the past year, and while the current price is slightly above the midpoint of this range, market confidence in its future performance appears to be waning.
See More
Precision Optics Prices Public Offering at $3.60 per Share
- Offering Size: Precision Optics announced the pricing of 2.78 million shares at $3.60 each, generating approximately $10 million in gross proceeds, indicating strong demand from both new and existing institutional investors, which reflects market confidence in the company.
- Underwriter Selection: Lucid Capital Markets has been appointed as the sole book-running manager for the offering, ensuring professionalism and efficiency in the underwriting process while also providing marketing support for the company.
- Additional Share Option: The company granted the underwriter a 45-day option to purchase up to an additional 416,667 shares at the offering price, enhancing the offering's flexibility and potential for increased capital inflow.
- Use of Proceeds: The net proceeds from this offering will be utilized for working capital and general corporate purposes, aimed at supporting the company's ongoing development and improving operational efficiency.
See More
Precision Optics Corporation Announces Pricing of Public Offering
- Offering Size: Precision Optics Corporation has priced its public offering at $3.60 per share for 2,777,777 shares, indicating strong market demand as the offering was oversubscribed, reflecting investor confidence in the company's future growth prospects.
- Management Participation: Key executives, including President and CEO Dr. Joseph N. Forkey and CFO Wayne Coll, participated in the offering by purchasing shares, which enhances market trust in the company's governance and growth potential.
- Use of Proceeds: The net proceeds from this offering will be utilized for general working capital and corporate purposes, expected to provide essential financial support for the company's ongoing development and expansion in the healthcare and defense/aerospace sectors.
- Underwriting Arrangement: Lucid Capital Markets is acting as the sole book-running manager for the offering and has been granted an option to purchase an additional 416,667 shares, demonstrating the underwriter's confidence and positive market response to the offering.
See More
Precision Optics Initiates Underwritten Public Offering
- Public Offering Launch: Precision Optics has announced the commencement of an underwritten public offering of its common stock, although it has not disclosed the size or pricing, indicating the company's intent to raise funds under current market conditions.
- Market Uncertainty: The company has not provided a timeline for the completion of the offering, suggesting that market conditions may impact the success of the offering, potentially affecting investor confidence.
- Underwriter Selection: Lucid Capital Markets has been appointed as the sole book-running manager, indicating a strategic choice by the company to ensure professionalism and efficiency in the offering process.
- Stock Price Volatility: Following the announcement of the offering, POCI's stock price fell by 5.79% to $4.23, reflecting market reactions to the offering and concerns regarding the company's short-term financial health.
See More
Precision Optics Corporation to Participate in Investor Conference
- Investor Conference Participation: Precision Optics Corporation will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026, featuring a webcast presentation and one-on-one meetings with investors to showcase its advanced optical instrument design and manufacturing capabilities in the medical and defense/aerospace sectors.
- Webcast Details: The webcast is scheduled to begin at 1:00 p.m. ET, and investors can access it via the conference homepage or directly through a provided link, with a replay available post-event to ensure information dissemination to those unable to attend live.
- One-on-One Meeting Arrangements: Management will engage in virtual one-on-one meetings throughout the event, allowing investors to arrange discussions through Lytham Partners, thereby enhancing understanding of the company's business and future developments.
- Company Background Overview: Founded in 1982, Precision Optics focuses on micro-optics, 3D imaging, and digital imaging technologies, providing comprehensive services from new product concepts to mass production, addressing the increasing demands of the healthcare and defense/aerospace markets.
See More
Precision Optics Reports Q3 Earnings with Strong Revenue Growth
- Significant Revenue Growth: Precision Optics reported Q3 revenue of $8.7 million, reflecting a 107.1% year-over-year increase, indicating strong performance amid market demand recovery, which is expected to further drive future financial results.
- Order Expansion: The company received a $3.5 million follow-on production order for its single-use ophthalmic program, with shipments expected to commence in the fourth fiscal quarter, enhancing the product line and boosting market competitiveness.
- Upward Financial Guidance: The company raised its fiscal year 2026 revenue guidance to a range of $29 to $31 million, up from the previous $26 to $28 million, reflecting confidence in future growth and projecting a 52% to 62% year-over-year increase.
- Improved EBITDA Expectations: The adjusted EBITDA guidance has also been revised upward to a range of $(2.5) to $(2.7) million, compared to the previous $(2.5) to $(3.0) million, demonstrating ongoing improvements in cost control and operational efficiency.
See More
Precision Optics Corporation Prices Public Offering
- Public Offering Pricing: Precision Optics Corporation has announced a public offering of 2.77 million shares at a price of $3.60 per share, which has led to a 2.72% decline in stock price to $4.12, indicating a negative market reaction to the offering.
- Underwriter Option: The company has granted the underwriter a 45-day option to purchase an additional 420,000 shares at the public offering price, which may provide the company with additional financial flexibility despite market volatility.
- Use of Proceeds: The net proceeds from this offering will be used for working capital and general corporate purposes, indicating the company's focus on enhancing financial stability while potentially facing challenges in capital efficiency.
- Market Performance: POCI shares have traded between $3.55 and $4.16 over the past year, and while the current price is slightly above the midpoint of this range, market confidence in its future performance appears to be waning.
See More
Precision Optics Prices Public Offering at $3.60 per Share
- Offering Size: Precision Optics announced the pricing of 2.78 million shares at $3.60 each, generating approximately $10 million in gross proceeds, indicating strong demand from both new and existing institutional investors, which reflects market confidence in the company.
- Underwriter Selection: Lucid Capital Markets has been appointed as the sole book-running manager for the offering, ensuring professionalism and efficiency in the underwriting process while also providing marketing support for the company.
- Additional Share Option: The company granted the underwriter a 45-day option to purchase up to an additional 416,667 shares at the offering price, enhancing the offering's flexibility and potential for increased capital inflow.
- Use of Proceeds: The net proceeds from this offering will be utilized for working capital and general corporate purposes, aimed at supporting the company's ongoing development and improving operational efficiency.
See More
Precision Optics Corporation Announces Pricing of Public Offering
- Offering Size: Precision Optics Corporation has priced its public offering at $3.60 per share for 2,777,777 shares, indicating strong market demand as the offering was oversubscribed, reflecting investor confidence in the company's future growth prospects.
- Management Participation: Key executives, including President and CEO Dr. Joseph N. Forkey and CFO Wayne Coll, participated in the offering by purchasing shares, which enhances market trust in the company's governance and growth potential.
- Use of Proceeds: The net proceeds from this offering will be utilized for general working capital and corporate purposes, expected to provide essential financial support for the company's ongoing development and expansion in the healthcare and defense/aerospace sectors.
- Underwriting Arrangement: Lucid Capital Markets is acting as the sole book-running manager for the offering and has been granted an option to purchase an additional 416,667 shares, demonstrating the underwriter's confidence and positive market response to the offering.
See More
Precision Optics Initiates Underwritten Public Offering
- Public Offering Launch: Precision Optics has announced the commencement of an underwritten public offering of its common stock, although it has not disclosed the size or pricing, indicating the company's intent to raise funds under current market conditions.
- Market Uncertainty: The company has not provided a timeline for the completion of the offering, suggesting that market conditions may impact the success of the offering, potentially affecting investor confidence.
- Underwriter Selection: Lucid Capital Markets has been appointed as the sole book-running manager, indicating a strategic choice by the company to ensure professionalism and efficiency in the offering process.
- Stock Price Volatility: Following the announcement of the offering, POCI's stock price fell by 5.79% to $4.23, reflecting market reactions to the offering and concerns regarding the company's short-term financial health.
See More
